What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
about
Psychostimulants and cognition: a continuum of behavioral and cognitive activationPharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)Caffeine for the prevention of injuries and errors in shift workersEffects of modafinil on the sleep EEG depend on Val158Met genotype of COMTControl of sleep and wakefulnessFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansPotential adverse effects of amphetamine treatment on brain and behavior: a reviewThe effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceSleep Quality Among Latino Farmworkers in North Carolina: Examination of the Job Control-Demand-Support ModelElectrophysiological correlates of sleep homeostasis in freely behaving ratsModeling fatigue over sleep deprivation, circadian rhythm, and caffeine with a minimal performance inhibitor modelEffects of sleep deprivation on central auditory processing.The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controlsThe Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention.Dopamine transporters govern diurnal variation in extracellular dopamine tone.VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors.The role of sleep hygiene in promoting public health: A review of empirical evidence.Neuropharmacology of Sleep and Wakefulness.Modafinil decreases food intake in humans subjected to simulated shift work.Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum.Neural correlates of sleepiness induced by catecholamine depletion.Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-AnalysisNeuropharmacology of Sleep and Wakefulness: 2012 Update.Clinical pharmacology in sleep medicine.Selectively driving cholinergic fibers optically in the thalamic reticular nucleus promotes sleepEffects of Alcohol, Coffee, and Tobacco, Alone or in Combination, on Physiological Parameters and Anxiety in a Young Population.Effects of sleep deprivation on neural functioning: an integrative review.Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controlsCircadian and sleep disorders in Parkinson's disease.Associations between secondhand smoke exposure and sleep patterns in childrenThe relationship between cocaine self-administration and actigraphy-based measures of sleep in adult rhesus monkeys.Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment.Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.How to fix a broken clock.Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations.The effects of theta-burst stimulation on sleep and vigilance in humans.Pharmacological modulation of lateral habenular dopamine D2 receptors alters the anxiogenic response to cocaine in a runway model of drug self-administration.
P2860
Q22242285-822B3745-B70A-4C53-B6EA-AD8A400DAF5DQ22251113-7D6A4505-4CBB-4519-BB18-41861BA46F45Q24235279-1A84127B-E3C4-441F-963B-4193A2DE416FQ24602466-FF4C9ADE-C9F1-4008-A6CF-B34C9FF1B1DEQ24634619-156784DE-A995-4C0E-93A3-88871DC6D4F0Q24654140-0B7702DE-AFC8-454F-B9FD-4DE526824001Q24657966-1C12EEAD-BD2C-4411-BA6C-77C55430B990Q28303831-84E401A3-DA89-4EF6-87C3-D62BEAF2250CQ28383843-FEE8432A-6C4C-45DC-B3D0-FA88806FB883Q28391321-3D1E98FC-D4FC-4D2F-8CCC-D7796A8CDCDFQ30437538-85E5FAB1-1268-498D-92B4-3FFA85C6AA85Q30464961-9A0212D1-A66F-4607-963C-3AEEF610B562Q30481775-63BA477A-1068-4733-AF33-9ACB1855F433Q33498962-811E0CAD-1C52-4D57-B9A0-3B999D6F6BA5Q33802902-3FCBD0CF-1861-4B33-9FDF-F3F633C28AE9Q33853949-C4E4F4F8-946A-4F7B-AACF-DB2E5AC4480EQ33921371-5869C8AC-A153-4767-902B-CCFA1859A03FQ34451125-C0947835-3264-43E7-AF33-D7334E146902Q34518670-C1A1ADE9-6051-405B-BF0B-3BDAA0B33095Q34788366-54FBFF34-1DC0-44AB-BBE3-0EE55D186E89Q35049293-8EEBC84D-D728-4E9F-BEEA-584A1C2E57A0Q35256340-D540A2AE-33DB-4C12-9173-8CCDC35F8E8DQ36090687-7ABAD8C8-CB83-496C-BA89-16C2561A9982Q36393701-52BCD1C3-32DF-4B84-9E5A-3E8091A0ED36Q36417984-0563EDA3-E5A3-439F-81C5-A1BEBB4DD74EQ36609980-6E0F5074-6978-442C-B9F8-289A9350D48DQ36752607-834E5A56-826A-46A1-9C1C-1109A208B78DQ36755406-1CAEC6BB-4C48-4737-9277-1BDBA70A9C2FQ36803329-E05E3BF2-A92F-4C73-BA12-26818D9505F0Q36882599-7F2CEDAC-9540-4ACB-AEF3-35B5F28135A8Q36988407-B0F2B739-5D55-49DF-A78C-D09E6D92DCEBQ37135120-AC7DAF44-C8F3-46B5-81F1-ED879514A28BQ37255555-2329C42E-0BE0-44EC-AFFC-2649EF723BAAQ37262032-4710AEF7-BC53-4309-A630-8D121510AEEFQ37271978-7C2ADB4E-0FD0-429C-854D-CB04870286CDQ37279144-81280FB3-632A-49F4-9495-A4FD45164915Q37375901-37E487D7-FB38-4DB4-914D-ACBB2BEBA8EAQ38645039-06A96CC4-DC2D-4C37-8CF1-116B1E27A190Q40597498-A5DDC6E8-1735-4F39-97BC-E42CDAF40D59Q41902898-4286760F-C5CC-4E56-8CC7-53C87D023C6B
P2860
What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
What keeps us awake: the neuro ...... fulness-promoting medications.
@ast
What keeps us awake: the neuro ...... fulness-promoting medications.
@en
What keeps us awake: the neuro ...... fulness-promoting medications.
@nl
type
label
What keeps us awake: the neuro ...... fulness-promoting medications.
@ast
What keeps us awake: the neuro ...... fulness-promoting medications.
@en
What keeps us awake: the neuro ...... fulness-promoting medications.
@nl
prefLabel
What keeps us awake: the neuro ...... fulness-promoting medications.
@ast
What keeps us awake: the neuro ...... fulness-promoting medications.
@en
What keeps us awake: the neuro ...... fulness-promoting medications.
@nl
P1433
P1476
What keeps us awake: the neuro ...... fulness-promoting medications.
@en
P2093
Benjamin Boutrel
George F Koob
P304
P577
2004-09-01T00:00:00Z